Sunshine Biopharma Inc Warrant
SBFMW
2 hedge funds and large institutions have $6.87K invested in Sunshine Biopharma Inc Warrant in 2024 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 2 reducing their positions, and 0 closing their positions.
33% more capital invested
Capital invested by funds: $5.16K → $6.87K (+$1.71K)
1.94% more ownership
Funds ownership: 0.2% → 2.14% (+1.9%)
0% more funds holding
Funds holding: 2 → 2 (0)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$574 |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$93 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $6.67K | -$574 | -3,700 | -8% |
|
|
2
UBS Group
Zurich,
Switzerland
| $208 | -$93 | -600 | -32% |
|
SBFMW Hedge Fund Activity: Q4 2024 in Review
2 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma Inc Warrant (SBFMW) for Q4 2024, worth a combined $6.87K — up 33% from $5.16K a quarter earlier.
Fund positioning in SBFMW was balanced in Q4 2024: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.
The largest seller was Citadel Advisors, cutting an estimated $574.
- 2 institutional investors held Sunshine Biopharma Inc Warrant (SBFMW) as of Q4 2024, unchanged from Q3 2024.
- Funds reported $6.87K of Sunshine Biopharma Inc Warrant stock for Q4 2024, up 33% quarter-over-quarter.
- 0 funds opened new Sunshine Biopharma Inc Warrant positions in Q4 2024 and 0 closed out.
- The largest Sunshine Biopharma Inc Warrant seller in Q4 2024 was Citadel Advisors, an estimated $574 sold.
Based on aggregated 13F filings for Q4 2024.